58 reports

  • D) Pipeline by program type
  • 2.6 Pathophysiology

Additionally, T##DM is an autoimmune disease.

  • Antidiabetics
  • World
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • Eli Lilly & Co.

Some of the major anti-diabetics drugs include Insulin, Pramlintide (Amylin), GLP-## receptor agonists (such as Byetta and Victoza), and Oral hypoglycemics (tablets). iii Anti-Thyroid Drugs companies produce drugs that can be used for treatment of an overactive thyroid (hyperthyroidism) caus

  • Antidiabetics
  • World
  • AstraZeneca PLC
  • Horizon Pharma plc
  • Novo Nordisk Group

In the next few years several major biologicals in oncology and the treatment of autoimmune diseases, accounting for more than Euros ## billion in spending, will lose their patent protection, opening the door to biosimilars.

  • Antidiabetics
  • World
  • Market Size
  • Amgen Inc.
  • Biocon Limited
  • Insulin Pumps Outlook

Insulin Pumps Outlook Type I Diabetes: Type I diabetes is an autoimmune disease that destroys the insulin producing beta cells in the pancreas of the human body.

  • Antidiabetics
  • Insulin Delivery
  • World
  • Market Size
  • Animas Corporation

Diabetes is one of the leading predisposing factors for chronic kidney disease (CKD).

  • Antidiabetics
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Novo Nordisk Group
  • Sanofi S.A.
  • Vendor landscape

Develops a platform technology to treat autoimmune diseases.

  • Antidiabetics
  • Diabetes
  • Insulin
  • United States
  • Eli Lilly & Co.
  • Focuses on improving its position in the global diabetes drugs market

About Type 2 Diabetes Diabetes, often referred to as diabetes mellitus, is a metabolic disease in which the patients' blood glucose levels remains high. Depending on the cause of development of diabetes, it can be divided into three types: - Type 1 diabetes (or insulin-dependent diabetes mellitus): In this condition, the pancreas...

  • Antidiabetics
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • Novo Nordisk Group
  • Sanofi S.A.
  • PROVIDES A SWOT ANALYSIS OF ELI LILLY. TABLE 114: ELI LILLY SWOT ANALYSIS, 2016
  • 10.3.2 NOVO NORDISK

ONE SUBJECT RECEIVING FORXIGA EXPERIENCED A LIVER AE WITH DIAGNOSES OF DRUG-INDUCED HEPATITIS AND/ OR AUTOIMMUNE HEPATITIS.

  • Antidiabetics
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • Novo Nordisk Group
  • Sanofi S.A.

Figure ##-##: Russia: Diabetes Population (Thousand), 2010 - 2017 Figure ##-##: Russia: Forecast for Diabetes Population (Thousand), 2018 - 2024 ##. ##. ## Type ## Diabetes Population and Forecast Type ## diabetes is an autoimmune disease that destroys the insulin-producing capaci

  • Antidiabetics
  • Northern Europe
  • Scandinavia
  • Western Europe
  • Forecast
  • Chapter V

Type ## diabetes is an autoimmune disease that results in the permanent destruction of insulin producing beta cells of the pancreas.

  • Antidiabetics
  • China
  • Demand
  • Market Size
  • Eli Lilly & Co.

THE COMPANY' S CLINICAL PIPELINE INCLUDES CANDIDATES IN MULTIPLE DISEASE AREAS, INCLUDING ATHEROSCLEROSIS, CANCER, CARDIOVASCULAR DISEASES, DIABETES, INFECTIOUS DISEASES, INFLAMMATORY/ AUTOIMMUNE DISEASES, INSOMNIA, NEURODEGENERATIVE DISEASES, OST

  • Antidiabetics
  • United States
  • Eli Lilly & Co.
  • Novo Nordisk Group
  • Takeda Pharmaceutical Company Limited
  • Vendor landscape

TOL-## by Tolerion is a DNA-based vaccine that encodes proinsulin and suppresses the body' s autoimmune action against insulin-producing cells.

  • Antidiabetics
  • Eli Lilly & Co.
  • Novo Nordisk Group
  • Oramed Pharmaceuticals Inc.
  • Sanofi S.A.

Nowadays, the availability of antibodies ranges from oncology indications to autoimmune diseases as well as rare ones like hemophilia and cystic fibrosis.

  • Antidiabetics
  • Biogen Idec Inc.
  • Novo Nordisk Group
  • Seattle Genetics, Inc.
  • Takeda Pharmaceutical Company Limited

FIGURE ##-##: RUSSIA: DIABETES POPULATION (THOUSAND), 2007 - 2015 FIGURE ##-##: RUSSIA: FORECAST FOR DIABETES POPULATION (THOUSAND), 2016 - 2020 ##. ##. ## RUSSIA TYPE ## DIABETES POPULATION AND FORECAST Type ## diabetes is an autoimmune disease that destroys the insulin-producing

  • Antidiabetics
  • Northern Europe
  • Western Europe
  • Forecast
  • Roche Group

(India) ##.

  • Analgesic
  • Antidiabetics
  • Cough And Cold
  • Pharmaceutical
  • Therapy

S##-S##. ##) Centers for Disease Control and Prevention (CDC) (2015).

  • Antidiabetics
  • United States
  • Eli Lilly & Co.
  • Novo Nordisk Group
  • Sanofi S.A.

FDC Ltd. (India)

3070 3500 2730

(India) ##.

  • Antidiabetics
  • Therapy
  • United States
  • World
  • Market Shares
  • Novo Nordisk

NPH human insulin Pre-mixed Insulin Long-acting insulin GLOBAL HUMAN INSULIN MARKET BY TYPE OF DISEASE 2014 PART ##: Market segmentation by type of disease Type ## Diabetes Type ## diabetes is an autoimmune disorder characterized by high blood glucose levels.

  • Antidiabetics
  • World
  • Lilly Endowment Inc.
  • Novo Nordisk Group
  • Sanofi S.A.

Its R& D is focused on the following six therapeutic areas: endocrine diseases, cancer, autoimmune diseases, neurological disorders, musculoskeletal disorders, and cardiovascular diseases.

  • Antidiabetics
  • Europe
  • Eli Lilly & Co.
  • Novo Nordisk Group
  • Sanofi S.A.
  • LARGE VOLUME WEARABLE INJECTORS FOR INSULIN: DEVICE PROFILES

ADDITIONALLY, PATIENTS SUFFERING FROM AUTOIMMUNE DISEASES, SUCH AS RHEUMATOID ARTHRITIS, REQUIRE FREQUENT INJECTIONS, WHICH NECESSITATES MULTIPLE VISITS TO A HOSPITAL OR CLINIC.

  • Antidiabetics
  • Debiotech S.A.
  • Medtronic, Inc.
  • Roche Group
  • West Pharmaceutical Services, Inc.
  • 7 Appendix
  • 4.3.1 MOLECULAR TARGET GROUPS IN THE PIPELINE

Antigen-specific immunotherapy for autoimmune disease: fighting fire with fire?

  • Antidiabetics
  • World
  • Eli Lilly & Co.
  • Lantus group
  • Novo Nordisk Group

OTHER PROMINENT DISEASE CATEGORIES ARE AUTOIMMUNE DISORDERS, RESPIRATORY DISEASES AND CARDIOVASCULAR DISEASES.

  • Antidiabetics
  • United States
  • Hospira, Inc.
  • Roche Group
  • Sandoz Inc.
  • UNMET NEED AND OPPORTUNITY IN T1D
  • 3.1.1 ETIOLOGY

A chronic autoimmune disease.

  • Antidiabetics
  • Eli Lilly & Co.
  • Lantus group
  • Novo Nordisk Group
  • Sanofi S.A.

THE COMPANY DELIVERS THERAPIES FOR DIABETES, CANCER AND AUTOIMMUNE DISEASES.

  • Antidiabetics
  • North America
  • United States
  • Market Size
  • Sandoz Inc.
  • 3. INTRODUCTION

AROUND ##-##% OF INDIVIDUALS DIAGNOSED WITH DIABETES ARE KNOWN TO SUFFER FROM THIS PARTICULAR TYPE OF THE DISEASE., IT IS A TYPE OF AUTOIMMUNE DISEASE, IN WHICH THE BODY' S IMMUNE SYSTEM ATTACKS AND DESTROYS THE INSULIN PRODUCING CELLS (BETA CELLS) OF THE PANCREAS.

  • Antidiabetics
  • North America
  • United States
  • Boehringer Ingelheim GmbH
  • Sanofi S.A.
  • UNMET NEED AND OPPORTUNITY IN T1D
  • 3.1.1 ETIOLOGY

A chronic autoimmune disease.

  • Antidiabetics
  • Eli Lilly & Co.
  • Lantus group
  • Novo Nordisk Group
  • Novolin R group
  • UNMET NEED AND OPPORTUNITY IN T1D
  • 3.1.1 ETIOLOGY

A chronic autoimmune disease.

  • Antidiabetics
  • Eli Lilly & Co.
  • Lantus group
  • Novo Nordisk Group
  • Novolin R group
  • UNMET NEED AND OPPORTUNITY IN T1D
  • 3.1.1 ETIOLOGY

A chronic autoimmune disease.

  • Antidiabetics
  • Eli Lilly & Co.
  • Lantus group
  • Novo Nordisk Group
  • Novolin R group
  • UNMET NEED AND OPPORTUNITY IN T1D
  • 3.1.1 ETIOLOGY

A chronic autoimmune disease.

  • Antidiabetics
  • Eli Lilly & Co.
  • Lantus group
  • Novo Nordisk Group
  • Novolin R group
  • 4 Current and Future Players

A chronic autoimmune disease.

  • Antidiabetics
  • Canada
  • North America
  • Eli Lilly & Co.
  • Novo Nordisk Group